You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
The fusion of light and immunity: Advancements in photoimmunotherapy for melanoma
Contributor:
Volety, Pranav;
Shirley, Carl A.;
Chhabra, Gagan;
Ahmad, Nihal
Published:
Wiley, 2024
Published in:
Photochemistry and Photobiology, 100 (2024) 4, Seite 910-922
Language:
English
DOI:
10.1111/php.13951
ISSN:
1751-1097;
0031-8655
Origination:
Footnote:
Description:
AbstractMetastatic melanoma is an aggressive skin cancer with high mortality and recurrence rates. Despite the clinical success of recent immunotherapy approaches, prevailing resistance rates necessitate the continued development of novel therapeutic options. Photoimmunotherapy (PIT) is emerging as a promising immunotherapy strategy that uses photodynamic therapy (PDT) to unleash systemic immune responses against tumor sites while maintaining the superior tumor‐specificity and minimally invasive nature of traditional PDT. In this review, we discuss recent advances in PIT and strategies for the management of melanoma using PIT. PIT can strongly induce immunogenic cell death, inviting the concomitant application of immune checkpoint blockade or adoptive cell therapies. PIT can also be leveraged to selectively remove the suppressive immune populations associated with immunotherapy resistance. The modular nature of PIT therapy design combined with the potential for patient‐specific antigen selection or drug co‐delivery makes PIT an alluring option for future personalized melanoma care.